ExodusPoint Capital Management, LP
Position in ZNTL — Zentalis Pharmaceuticals, Inc.
CIK 1736225
NEW YORK, NY
Position in ZNTL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$363,585
-$155,761 QoQ
Shares Held
74,966
+307.2% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 114 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZNTL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ExodusPoint Capital Management, LP holds $280,525,216 across 101 Biotechnology names. ZNTL ranks #77 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
249,259 | $21,234,374 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
224,927 | $16,752,562 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
148,212 | $14,105,336 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
361,126 | $14,087,525 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
53,201 | $12,819,844 | |
| 6 | NAMS |
NewAmsterdam Pharma Co N.V.
|
304,334 | $10,313,879 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
164,513 | $9,038,344 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
336,567 | $8,656,503 |
All Filings in ZNTL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $363,585 | 74,966 | Shares | Sole | 2026-08-14 | |
| 2023-06-30 | $519,346 | 18,410 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $1,282,982 | 74,592 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,724,890 | 85,645 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,421,608 | 157,969 | Shares | Other | 2022-11-10 | |
| 2021-06-30 | $281,960 | 5,300 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||